“…The possibility of isolating and expanding autologous bone marrow stromal cells (BMSCs) and driving them towards the osteogenic (Friedenstein et al, 1968;Pittenger et al, 1999;Prockop, 1997), neural (Sanchez-Ramos et al, 2000;Woodbury et al, 2000) or cardiomyocytic (Toma et al, 2002) phenotypes presents a high potential for numerous applications of cell therapy (Bang et al, 2005;Quarto et al, 2001;Shyu et al, 2006;Tomita *Correspondence to: Esther Potier, Laboratoire de Recherches Orthopédiques (B2OA), UMR CNRS 7052, Faculté de Médecine Lariboisière-Saint-Louis, 10 Avenue de Verdun, 75010 Paris, France. E-mail: esther.potier@gmail.com et al, 1999).…”